<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<tbody>
<tr stylecode="Botrule">
<td align="center" stylecode="Lrule Rrule" valign="top">Concomitant Drug<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">Effect on Concentration<br/>of Lamotrigine or<br/>Concomitant Drug<br/>
</td>
<td align="center" stylecode="Rrule" valign="top"> <br/>Clinical Comment<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Estrogen-containing oral contraceptive preparation containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel<br/>
</td>
<td stylecode="Rrule" valign="top">↓ lamotrigine<br/> <br/>
</td>
<td stylecode="Rrule" valign="top">Decreased lamotrigine levels approximately 50%.<br/> <br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <br/>
</td>
<td stylecode="Rrule" valign="top">↓ levonorgestrel<br/>
</td>
<td stylecode="Rrule" valign="top">Decrease in levonorgestrel component by 19%.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Carbamazepine (CBZ) and CBZ epoxide<br/>
</td>
<td stylecode="Rrule" valign="top">↓ lamotrigine<br/>
</td>
<td stylecode="Rrule" valign="top">Addition of carbamazepine decreases lamotrigine concentration approximately 40%.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <br/>
</td>
<td stylecode="Rrule" valign="top">? CBZ epoxide<br/>
</td>
<td stylecode="Rrule" valign="top">May increase CBZ epoxide levels<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Phenobarbital/Primidone<br/>
</td>
<td stylecode="Rrule" valign="top">↓ lamotrigine<br/>
</td>
<td stylecode="Rrule" valign="top">Decreased lamotrigine concentration approximately 40%.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Phenytoin (PHT)<br/>
</td>
<td stylecode="Rrule" valign="top">↓ lamotrigine<br/>
</td>
<td stylecode="Rrule" valign="top">Decreased lamotrigine concentration approximately 40%.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Rifampin<br/>
</td>
<td stylecode="Rrule" valign="top">↓ lamotrigine<br/>
</td>
<td stylecode="Rrule" valign="top">Decreased lamotrigine AUC approximately 40%.<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Valproate<br/>
</td>
<td stylecode="Rrule" valign="top">↑ lamotrigine<br/>
</td>
<td stylecode="Rrule" valign="top">Increased lamotrigine concentrations slightly more than 2-fold.<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top"> <br/>
</td>
<td stylecode="Rrule" valign="top">? valproate<br/>
</td>
<td stylecode="Rrule" valign="top">Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients.<br/> <br/>
</td>
</tr>
</tbody>
</table>